No retraction, correction or concern found when last checked on Oct 18, 2026.

Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations

Frans P.M. Cremers, Winston Lee, Rob W.J. Collin and 1 more

Progress in Retinal and Eye Research · 2020 · Review · CC BY

doi:10.1016/j.preteyeres.2020.100861

Abstract

The ABCA4 protein (then called a "rim protein") was first identified in 1978 in the rims and incisures of rod photoreceptors. The corresponding gene, ABCA4, was cloned in 1997, and variants were identified as the cause of autosomal recessive Stargardt disease (STGD1). Over the next two decades, variation in ABCA4 has been attributed to phenotypes other than the classically defined STGD1 or fundus flavimaculatus, ranging from early onset and fast progressing cone-rod dystrophy and retinitis pigmentosa-like phenotypes to very late onset cases of mostly mild disease sometimes resembling, and confused with, age-related macular degeneration. Similarly, analysis of the ABCA4 locus uncovered a trove of genetic information, including >1200 disease-causing mutations of varying severity, and of all types - missense, nonsense, small deletions/insertions, and splicing affecting variants, of which many are located deep-intronic. Altogether, this has greatly expanded our understanding of complexity not only of the diseases caused by ABCA4 mutations, but of all Mendelian diseases in general. This review provides an in depth assessment of the cumulative knowledge of ABCA4-associated retinopathy - clinical manifestations, genetic complexity, pathophysiology as well as current and proposed therapeutic approaches.

References 290

1.
Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS, Cideciyan AV, Pearce-Kelling SE, Anand V, Zeng Y, Maguire AM, Jacobson SG, Hauswirth WW, Bennett J, 2001. Gene therapy restores vision in a canine model of childhood blindness. Nat. Genet 28, 92–95.
Not in our library10.1038/ng0501-92
2.
Acton JH, Greenstein VC, 2013. Fundus-driven perimetry (microperimetry) compared to conventional static automated perimetry: similarities, differences, and clinical applications. Can. J. Ophthalmol 48, 358–363.
Not in our library10.1016/j.jcjo.2013.03.021
3.
Agbaga MP, Brush RS, Mandal MN, Henry K, Elliott MH, Anderson RE, 2008. Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids. Proc. Natl. Acad. Sci. U. S. A 105, 12843–12848.
Not in our library10.1073/pnas.0802607105
4.
Aguirre-Lamban J, Gonzalez-Aguilera JJ, Riveiro-Alvarez R, Cantalapiedra D, Avila-Fernandez A, Villaverde-Montero C, Corton M, Bianco-Kelly F, Garcia-Sandoval B, Ayuso C, 2011. Further associations between mutations and polymorphisms in the ABCA4 gene: clinical implication of allelic variants and their role as protector/risk factors. Invest. Ophthalmol. Vis. Sci 52, 6206–6212.
Not in our library10.1167/iovs.10-5743
5.
Ahn J, Molday RS, 2000. Purification and characterization of ABCR from bovine rod outer segments. Methods Enzymol. 315, 864–879.
Not in our library10.1016/s0076-6879(00)15887-2
6.
Alabduljalil T, Patel RC, Alqahtani AA, Gao SS, Gale MJ, Zhang M, Jia Y, Huang D, Chiang PW, Chen R, Wang J, Weleber RG, Pennesi ME, Yang P, 2019. Correlation of outer retinal degeneration and choriocapillaris loss in stargardt disease using en face optical coherence tomography and optical coherence tomography angiography. Am. J. Ophthalmol 202, 79–90.
Not in our library10.1016/j.ajo.2019.02.007
7.
Albert S, Garanto A, Sangermano R, Khan M, Bax NM, Hoyng CB, Zernant J, Lee W, Allikmets R, Collin RWJ, Cremers FPM, 2018. Identification and rescue of splice defects caused by two neighboring deep-intronic ABCA4 mutations underlying stargardt disease. Am. J. Hum. Genet 102, 517–527.
Not in our library10.1016/j.ajhg.2018.02.008
8.
Aldahmesh MA, Mohamed JY, Alkuraya HS, Verma IC, Puri RD, Alaiya AA, Rizzo WB, Alkuraya FS, 2011. Recessive mutations in ELOVL4 cause ichthyosis, intellectual disability, and spastic quadriplegia. Am. J. Hum. Genet 89, 745–750.
Not in our library10.1016/j.ajhg.2011.10.011
9.
Allikmets R, 2000. Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. Am. J. Hum. Genet 67, 487–491.
Not in our library10.1086/303018
10.
Allikmets R, 2007. Stargardt disease: from gene discovery to therapy. In: Tombran-Tink J, Barnstable CJ (Eds.), Biology. Diagnostics and Therapeutics Humana Press, Totowa, NJ, pp. 105–118 Retinal Degenerations.
Not in our library
11.
Allikmets R, Singh N, Sun H, Shroyer NF, Hutchinson A, Chidambaram A, Gerrard B, Baird L, Stauffer D, Peiffer A, Rattner A, Smallwood P, Li Y, Anderson KL, Lewus RA, Nathans J, Leppert M, Dean M, Lupski JR, 1997. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat. Genet 15, 236–246.
Not in our library10.1038/ng0397-236
12.
Allikmets R, Zernant J, Lee W, 2018. Penetrance of the ABCA4 p.Asn1868Ile allele in stargardt disease. Invest. Ophthalmol. Vis. Sci 59, 5564–5565.
Not in our library10.1167/iovs.18-25579
13.
Anderson KL, Baird L, Lewds RA, Chinault AC, Otterud B, Leppert M, Lupski JR, 1995. A YAC contig encompassing the recessive Stargardt disease gene (STGD) on chromosome 1p. Am. J. Hum. Genet 57, 1351–1363.
Not in our library
14.
Anmarkrud N, 1979. Fundus fluorescein angiography in fundus flavimaculatus and Stargardts disease. Acta Ophthalmol. 57, 172–182.
Not in our library10.1111/j.1755-3768.1979.tb00482.x
15.
Arepalli S, Traboulsi EI, Ehlers JP, 2018. Ellipsoid zone mapping and outer retinal assessment in stargardt disease. Retina 38, 1427–1431.
Not in our library10.1097/iae.0000000000001716
16.
Bauwens M, De Zaeytijd J, Weisschuh N, Kohl S, Meire F, Dahan K, Depasse F, De Jaegere S, De Ravel T, De Rademaeker M, Loeys B, Coppieters F, Leroy BP, De Baere E, 2015. An augmented ABCA4 screen targeting noncoding regions reveals a deep intronic founder variant in Belgian Stargardt patients. Hum. Mutat 36, 39–42.
Not in our library10.1002/humu.22716
17.
Bauwens M, Garanto A, Sangermano R, Naessens S, Weisschuh N, De Zaeytijd J, Khan M, Sadler F, Balikova I, Van Cauwenbergh C, Rosseel T, Bauwens J, De Leeneer K, De Jaegere S, Van Laethem T, De Vries M, Carss K, Arno G, Fakin A, Webster AR, de Ravel de l’Argentiere TJL, Sznajer Y, Vuylsteke M, Kohl S, Wissinger B, Cherry T, Collin RWJ, Cremers FPM, Leroy BP, De Baere E, 2019. ABCA4-associated disease as a model for missing heritability in autosomal recessive disorders: novel noncoding splice, cis-regulatory, structural, and recurrent hypomorphic variants. Genet. Med 21, 1761–1771.
Not in our library10.1038/s41436-018-0420-y
18.
Bax NM, Sangermano R, Roosing S, Thiadens AA, Hoefsloot LH, van den Born LI, Phan M, Klevering BJ, Westeneng-van Haaften C, Braun TA, Zonneveld-Vrieling MN, de Wijs I, Mutlu M, Stone EM, den Hollander AI, Klaver CC, Hoyng CB, Cremers FP, 2015. Heterozygous deep-intronic variants and deletions in ABCA4 in persons with retinal dystrophies and one exonic ABCA4 variant. Hum. Mutat 36, 43–47.
Not in our library10.1002/humu.22717
19.
Bax NM, Lambertus S, Cremers FPM, Klevering BJ, Hoyng CB, 2019a. The absence of fundus abnormalities in Stargardt disease. Graefes Arch. Clin. Exp. Ophthalmol 257, 1147–1157.
Not in our library10.1007/s00417-019-04280-8
20.
Bax NM, Valkenburg D, Lambertus S, Klevering BJ, Boon CJF, Holz FG, Cremers FPM, Fleckenstein M, Hoyng CB, Lindner M, for the Foveal Sparing Atrophy Study, 2019b. Foveal sparing in central retinal dystrophies. T. Invest. Ophthalmol. Vis. Sci 60, 3456–3467.
Not in our library10.1167/iovs.18-26533
21.
Beharry S, Zhong M, Molday RS, 2004. N-retinylidene-phosphatidylethanolamine is the preferred retinoid substrate for the photoreceptor-specific ABC transporter ABCA4 (ABCR). J. Biol. Chem 279, 53972–53979.
Not in our library10.1074/jbc.m405216200
22.
Beit-Ya’acov A, Mizrahi-Meissonnier L, Obolensky A, Landau C, Blumenfeld A, Rosenmann A, Banin E, Sharon D, 2007. Homozygosity for a novel ABCA4 founder splicing mutation is associated with progressive and severe Stargardt-like disease. Invest. Ophthalmol. Vis. Sci 48, 4308–4314.
Not in our library10.1167/iovs.07-0244
23.
Bernstein A, Sunness JS, Applegate CA, Tegins EO, 2016. Mapping the dense scotoma and its enlargement in stargardt disease. Retina 36, 1741–1750.
Not in our library10.1097/iae.0000000000001003
24.
Bertelsen M, Zernant J, Larsen M, Duno M, Allikmets R, Rosenberg T, 2014. Generalized choriocapillaris dystrophy, a distinct phenotype in the spectrum of ABCA4-associated retinopathies. Invest. Ophthalmol. Vis. Sci 55, 2766–2776.
Not in our library10.1167/iovs.13-13391
25.
Decreased fixation stability of the preferred retinal location in juvenile macular degeneration. · 2014
Not checked
26.
Billon P, Bryant EE, Joseph SA, Nambiar TS, Hayward SB, Rothstein R, Ciccia A, 2017. CRISPR-mediated base editing enables efficient disruption of eukaryotic genes through induction of STOP codons. Mol. Cell. 67, 1068–1079 e1064.
Not in our library10.1016/j.molcel.2017.08.008
27.
Birch DG, Peters AY, Locke KL, Spencer R, Megarity CF, Travis GH, 2001. Visual function in patients with cone-rod dystrophy (CRD) associated with mutations in the ABCA4(ABCR) gene. Exp. Eye Res 73, 877–886.
Not in our library10.1006/exer.2001.1093
28.
Birnbach CD, Jarvelainen M, Possin DE, Milam AH, 1994. Histopathology and immunocytochemistry of the neurosensory retina in fundus flavimaculatus. Ophthalmology 101, 1211–1219.
Not in our library10.1016/s0161-6420(13)31725-4
29.
Clinical and genetic characteristics of 251 consecutive patients with macular and cone/cone-rod dystrophy · 2018
No notice
30.
Blacharski P, 1988. Retinal Dystrophies and Degenerations. Raven Press, New York.
Not in our library
31.
Bok D, 2005. Cellular mechanisms of retinal degenerations: RPE65, ABCA4, RDS, and bicarbonate transporter genes as examples. Retina 25, S18–S20.
Not in our library10.1097/00006982-200512001-00007
32.
Braun TA, Mullins RF, Wagner AH, Andorf JL, Johnston RM, Bakall BB, Deluca AP, Fishman GA, Lam BL, Weleber RG, Cideciyan AV, Jacobson SG, Sheffield VC, Tucker BA, Stone EM, 2013. Non-exomic and synonymous variants in ABCA4 are an important cause of Stargardt disease. Hum. Mol. Genet 22, 5136–5145.
Not in our library10.1093/hmg/ddt367
33.
Burke TR, Fishman GA, Zernant J, Schubert C, Tsang SH, Smith RT, Ayyagari R, Koenekoop RK, Umfress A, Ciccarelli ML, Baldi A, Iannaccone A, Cremers FP, Klaver CC, Allikmets R, 2012. Retinal phenotypes in patients homozygous for the G1961E mutation in the ABCA4 gene. Invest. Ophthalmol. Vis. Sci 53, 4458–4467.
Not in our library10.1167/iovs.11-9166
34.
Burke TR, Yzer S, Zernant J, Smith RT, Tsang SH, Allikmets R, 2013. Abnormality in the external limiting membrane in early Stargardt disease. Ophthalmic Genet. 34, 75–77.
Not in our library10.3109/13816810.2012.707271
35.
Burke TR, Duncker T, Woods RL, Greenberg JP, Zernant J, Tsang SH, Smith RT, Allikmets R, Sparrow JR, Delori FC, 2014. Quantitative fundus autofluorescence in recessive Stargardt disease. Invest. Ophthalmol. Vis. Sci 55, 2841–2852.
Not in our library10.1167/iovs.13-13624
36.
Cai CX, Light JG, Handa JT, 2018. Quantifying the rate of ellipsoid zone loss in stargardt disease. Am. J. Ophthalmol 186, 1–9.
Not in our library10.1016/j.ajo.2017.10.032
37.
Carss KJ, Arno G, Erwood M, Stephens J, Sanchis-Juan A, Hull S, Megy K, Grozeva D, Dewhurst E, Malka S, Plagnol V, Penkett C, Stirrups K, Rizzo R, Wright G, Josifova D, Bitner-Glindzicz M, Scott RH, Clement E, Allen L, Armstrong R, Brady AF, Carmichael J, Chitre M, Henderson RHH, Hurst J, MacLaren RE, Murphy E, Paterson J, Rosser E, Thompson DA, Wakeling E, Ouwehand WH, Michaelides M, Moore AT, Consortium NI-BRD, Webster AR, Raymond FL, 2017. Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease. Am. J. Hum. Genet 100, 75–90.
Not in our library10.1016/j.ajhg.2016.12.003
38.
Celia W, Greenstein VC, Zernant-Rajang J, Smith TR, Barile G, Allikmets R, Tsang SH, 2009. G1961E mutant allele in the Stargardt disease gene ABCA4 causes bull’s eye maculopathy. Exp. Eye Res 89, 16–24.
Not in our library10.1016/j.exer.2009.02.001
39.
Chacon-Camacho OF, Granillo-Alvarez M, Ayala-Ramirez R, Zenteno JC, 2013. ABCA4 mutational spectrum in Mexican patients with Stargardt disease: identification of 12 novel mutations and evidence of a founder effect for the common p.A1773V mutation. Exp. Eye Res 109, 77–82.
Not in our library10.1016/j.exer.2013.02.006
40.
Chapi M, Sabbaghi H, Suri F, Alehabib E, Rahimi-Aliabadi S, Jamali F, Jamshidi J, Emamalizadeh B, Darvish H, Mirrahimi M, Ahmadieh H, Daftarian N, 2019. Incomplete penetrance of CRX gene for autosomal dominant form of cone-rod dystrophy. Ophthalmic Genet. 40, 259–266.
Not in our library10.1080/13816810.2019.1622023
41.
Charbel Issa P, Barnard AR, Singh MS, Carter E, Jiang Z, Radu RA, Schraermeyer U, MacLaren RE, 2013. Fundus autofluorescence in the Abca4(-/-) mouse model of Stargardt disease-correlation with accumulation of A2E, retinal function, and histology. Invest. Ophthalmol. Vis. Sci 54, 5602–5612.
Not in our library10.1167/iovs.13-11688
42.
Charbel Issa P, Barnard AR, Herrmann P, Washington I, MacLaren RE, 2015. Rescue of the Stargardt phenotype in Abca4 knockout mice through inhibition of vitamin A dimerization. Proc. Natl. Acad. Sci. U. S. A 112, 8415–8420.
Not in our library10.1073/pnas.1506960112
43.
Chen B, Tosha C, Gorin MB, Nusinowitz S, 2010. Analysis of autofluorescent retinal images and measurement of atrophic lesion growth in Stargardt disease. Exp. Eye Res 91, 143–152.
Not in our library10.1016/j.exer.2010.03.021
44.
Chen L, Lee W, de Carvalho JRL Jr., Chang S, Tsang SH, Allikmets R, Sparrow JR, 2019. Multi-platform imaging in ABCA4-associated disease. Sci. Rep 9, 6436.
Not in our library10.1038/s41598-019-42772-z
45.
Cherry TJ, Yang MG, Harmin DA, Tao P, Timms AE, Bauwens M, Allikmets R, Jones EM, Chen R, De Baere E, Greenberg ME, 2020. Mapping the cfs-regulatory architecture of the human retina reveals noncoding genetic variation in disease. Proc. Natl. Acad. Sci. U. S. A 117, 9001–9012. https://www.pnas.org/content/117/16/9001.
Not in our library10.1073/pnas.1922501117
46.
Cideciyan AV, Aleman TS, Swider M, Schwartz SB, Steinberg JD, Brucker AJ, Maguire AM, Bennett J, Stone EM, Jacobson SG, 2004. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum. Mol. Genet 13, 525–534.
Not in our library10.1093/hmg/ddh048
47.
Cideciyan AV, Swider M, Aleman TS, Sumaroka A, Schwartz SB, Roman MI, Milam AH, Bennett J, Stone EM, Jacobson SG, 2005. ABCA4-associated retinal degenerations spare structure and function of the human parapapillary retina. Invest. Ophthalmol. Vis. Sci 46, 4739–4746.
Not in our library10.1167/iovs.05-0805
48.
Cideciyan AV, Swider M, Aleman TS, Roman MI, Sumaroka A, Schwartz SB, Stone EM, Jacobson SG, 2007. Reduced-illuminance autofluorescence imaging in ABCA4-associated retinal degenerations. J Opt Soc Am A Opt Image Sci Vis 24, 1457–1467.
Not in our library10.1364/josaa.24.001457
49.
Cideciyan AV, Swider M, Aleman TS, Feuer WJ, Schwartz SB, Russell RC, Steinberg JD, Stone EM, Jacobson SG, 2012. Macular function in macular degenerations: repeatability of microperimetry as a potential outcome measure for ABCA4-associated retinopathy trials. Invest. Ophthalmol. Vis. Sci 53, 841–852.
Not in our library10.1167/iovs.11-8415
50.
Cideciyan AV, Swider M, Schwartz SB, Stone EM, Jacobson SG, 2015. Predicting progression of ABCA4-associated retinal degenerations based on longitudinal measurements of the leading disease front. Invest. Ophthalmol. Vis. Sci 56, 5946–5955.
Not in our library10.1167/iovs.15-17698
51.
Cideciyan AV, Jacobson SG, Drack AV, Ho AC, Charng J, Garafalo AV, Roman AJ, Sumaroka A, Han IC, Hochstedler MD, Pfeifer WL, Sohn EH, Taiel M, Schwartz MR, Biasutto P, Wit W, Cheetham ME, Adamson P, Rodman DM, Platenburg G, Tome MD, Balikova I, Nerinckx F, Zaeytijd J, Van Cauwenbergh B, Leroy BP, Russell SR, 2019. Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect. Nat. Med 25, 225–228.
Not in our library10.1038/s41591-018-0295-0
52.
Collin RW, den Hollander AI, van der Velde-Visser SD, Bennicelli J, Bennett J, Cremers FP, 2012. Antisense oligonucleotide (AON)-based therapy for leber congenital amaurosis caused by a frequent mutation in CEP290. Mol. Ther. Nucleic Acids 1, el4.
Not in our library10.1038/mtna.2012.3
53.
Collison FT, Fishman GA, 2018. Visual acuity in patients with stargardt disease after age 40. Retina 38, 2387–2394.
Not in our library10.1097/iae.0000000000001903
54.
Collison FT, Fishman GA, McAnany JJ, Zernant J, Allikmets R, 2014. Psychophysical measurement of rod and cone thresholds in stargardt disease with full-field stimuli. Retina 34, 1888–1895.
Not in our library10.1097/iae.0000000000000144
55.
Collison FT, Lee W, Fishman GA, Park JC, Zernant J, McAnany JJ, Allikmets R, 2019. Clinical characterization of Stargardt disease patients with the p.N1868I ABCA4 mutation. Retina 39, 2311–2325.
Not in our library10.1097/iae.0000000000002316
56.
Cornells SS, Bax NM, Zernant J, Allikmets R, Fritsche LG, den Dunnen JT, Ajmal M, Hoyng CB, Cremers FP, 2017. Silico functional meta-analysis of 5,962 ABCA4 variants in 3,928 retinal dystrophy cases. Hum. Mutat 38, 400–408.
Not in our library10.1002/humu.23165
57.
Cremers FP, van de Pol DJ, van Driel M, den Hollander AI, van Haren FJ, Knoers NV, Tijmes N, Bergen AA, Rohrschneider K, Blankenagel A, Pinckers AJ, Deutman AF, Hoyng CB, 1998. Autosomal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardťs disease gene ABCR. Hum. Mol. Genet 7, 355–362.
Not in our library10.1093/hmg/7.3.355
58.
Cremers FP, Maugeri A, den Hollander AI, Hoyng CB, 2004. The expanding roles of ABCA4 and CRB1 In inherited blindness. Novartis Found Symp 255,68–79; discussion 79–84, 177–178.
Not in our library10.1002/0470092645.ch6
59.
Cremers FPM, Cornells SS, Runhart EH, Astuti GDN, 2018. Author response: penetrance of the ABCA4 p.Asn1868Ile allele in stargardt disease. Invest. Ophthalmol. Vis. Sci 59, 5566–5568.
Not in our library10.1167/iovs.18-25944
60.
Cukras CA, Wong WT, Caruso R, Cunningham D, Zein W, Sieving PA, 2012. Centrifugal expansion of fundus autofluorescence patterns in Stargardt disease over time. Arch. Ophthalmol 130, 171–179.
Not in our library10.1001/archophthalmol.2011.332
61.
Dahl SG, Sylte I, Ravna AW, 2004. Structures and models of transporter proteins. J. Pharmacol. Exp. Therapeut 309, 853–860.
Not in our library10.1124/jpet.103.059972
62.
Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, Welter JJ, 1995. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest. Ophthalmol. Vis. Sci 36, 718–729.
Not in our library
63.
Delori FC, Goger DG, Dorey CK, 2001. Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. Invest. Ophthalmol. Vis. Sci 42, 1855–1866.
Not in our library
64.
Delori F, Greenberg JP, Woods RL, Fischer J, Duncker T, Sparrow J, Smith RT, 2011. Quantitative measurements of autofluorescence with the scanning laser ophthalmoscope. Invest. Ophthalmol. Vis. Sci 52, 9379–9390.
Not in our library10.1167/iovs.11-8319
65.
Deutman AF, 1971. The hereditary dystrophies of the posterior pole of the eye van Gorcum & Comp. N.V.
Not in our library
66.
Drolet DW, Green LS, Gold L, Janjic N, 2016. Fit for the eye: aptamers in ocular disorders. Nucleic Acid Therapeut 26, 127–146.
Not in our library10.1089/nat.2015.0573
67.
Ducroq D, Shalev S, Habib A, Munnich A, Kaplan J, Rozet JM, 2006. Three different ABCA4 mutations in the same large family with several consanguineous loops affected with autosomal recessive cone-rod dystrophy. Eur. J. Hum. Genet 14, 1269–1273.
Not in our library10.1038/sj.ejhg.5201691
68.
Dugel PU, Novack RL, Csaky KG, Richmond PP, Birch DG, Kubota R, 2015. Phase ii, randomized, placebo-controlled, 90-day study of emixustat hydrochloride in geographic atrophy associated with dry age-related macular degeneration. Retina 35, 1173–1183.
Not in our library10.1097/iae.0000000000000606
69.
Splice-Modulating Oligonucleotide QR-110 Restores CEP290 mRNA and Function in Human c.2991+1655A>G LCA10 Models · 2018
No notice
70.
Duncker T, Lee W, Tsang SH, Greenberg JP, Zernant J, Allikmets R, Sparrow JR, 2013. Distinct characteristics of inferonasal fundus autofluorescence patterns in stargardt disease and retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci 54, 6820–6826.
Not in our library10.1167/iovs.13-12895
71.
Duncker T, Marsiglia M, Lee W, Zernant J, Tsang SH, Allikmets R, Greenstein VC, Sparrow JR, 2014. Correlations among near-infrared and short-wavelength autofluorescence and spectral-domain optical coherence tomography in recessive Stargardt disease. Invest. Ophthalmol. Vis. Sci 55, 8134–8143.
Not in our library10.1167/iovs.14-14848
72.
Duncker T, Stein GE, Lee W, Tsang SH, Zernant J, Bearelly S, Hood DC, Greenstein VC, Delori FC, Allikmets R, Sparrow JR, 2015a. Quantitative fundus autofluorescence and optical coherence tomography in ABCA4 carriers. Invest. Ophthalmol. Vis. Sci 56, 7274–7285.
Not in our library10.1167/iovs.15-17371
73.
Duncker T, Tsang SH, Lee W, Zernant J, Allikmets R, Delori FC, Sparrow JR, 2015b. Quantitative fundus autofluorescence distinguishes ABCA4-associated and non-ABCA4-associated bull’s-eye maculopathy. Ophthalmology 122, 345–355.
Not in our library10.1016/j.ophtha.2014.08.017
74.
Duncker T, Tsang SH, Woods RL, Lee W, Zernant J, Allikmets R, Delori FC, Sparrow JR, 2015c. Quantitative fundus autofluorescence and optical coherence tomography in PRPH2/RDS- and ABCA4-associated disease exhibiting phenotypic overlap. Invest. Ophthalmol. Vis. Sci 56, 3159–3170.
Not in our library10.1167/iovs.14-16343
75.
Dyka FM, Molday LL, Chiodo VA, Molday RS, Hauswirth WW, 2019. Dual ABCA4-AAV vector treatment reduces pathogenic retinal A2E accumulation in a mouse model of autosomal recessive stargardt disease. Hum. Gene Ther 30, 1361–1370.
Not in our library10.1089/hum.2019.132
76.
Eagle RC Jr., Lucier AC, Bernardino VB Jr., Yanoff M, 1980. Retinal pigment epithelial abnormalities in fundus flavimaculatus: a light and electron microscopic study. Ophthalmology 87, 1189–1200.
Not in our library10.1016/s0161-6420(80)35106-3
77.
Ergun E, Hermann B, Wirtitsch M, Unterhuber A, Ko TH, Sattmann H, Scholda C, Fujimoto JG, Stur M, Drexler W, 2005. Assessment of central visual function in Stargardťs disease/fundus flavimaculatus with ultrahigh-resolution optical coherence tomography. Invest. Ophthalmol. Vis. Sci 46, 310–316.
Not in our library10.1167/iovs.04-0212
78.
Ernest JT, Krill AE, 1966. Fluorescein studies in fundus flavimaculatus and drusen. Am. J. Ophthalmol 62, 1–6.
Not in our library10.1016/0002-9394(66)91668-0
79.
Fadaie Z, Khan M, Del Pozo-Valero M, Cornells SS, Ayuso C, Cremers FPM, Roosing S, The ABCA4 Study Group, 2019. Identification of splice defects due to noncanonical splice site or deep-intronic variants in ABCA4. Hum. Mutat 40, 2365–2376.
Not in our library10.1002/humu.23890
80.
Falfoul Y, Habibi I, Turki A, Chebil A, Hassairi A, Schorderet DF, El Matri L, 2018. Phenotypic progression of stargardt disease in a large consanguineous Tunisian family harboring new ABCA4 mutations. J Ophthalmol 2018, 1030184.
Not in our library10.1155/2018/1030184
81.
Fingert JH, Eliason DA, Phillips NC, Lotery AJ, Sheffield VC, Stone EM, 2006. Case of Stargardt disease caused by uniparental isodisomy. Arch. Ophthalmol 124, 744–745.
Not in our library10.1001/archopht.124.5.744
82.
Fish G, Grey R, Sehmi KS, Bird AC, 1981. The dark choroid in posterior retinal dystrophies. Br. J. Ophthalmol 65, 359–363.
Not in our library10.1136/bjo.65.5.359
83.
Fishkin NE, Sparrow JR, Allikmets R, Nakanishi K, 2005. Isolation and characterization of a retinal pigment epithelial cell fluorophore: an all-trans-retinal dimer conjugate. Proc. Natl. Acad. Sci. U. S. A 102, 7091–7096.
Not in our library10.1073/pnas.0501266102
84.
Fishman GA, 1976. Fundus flavimaculatus. A clinical classification. Arch. Ophthalmol 94, 2061–2067.
Not in our library10.1001/archopht.1976.03910040721003
85.
Fishman GA, Stone EM, Grover S, Derlacki DJ, Haines HL, Hockey RR, 1999. Variation of clinical expression in patients with Stargardt dystrophy and sequence variations in the ABCR gene. Arch. Ophthalmol 117, 504–510.
Not in our library10.1001/archopht.117.4.504
86.
Fliesler SJ, Anderson RE, 1983. Chemistry and metabolism of lipids in the vertebrate retina. Prog. Lipid Res 22, 79–131.
Not in our library10.1016/0163-7827(83)90004-8
87.
Franceschetti A, 1965. A special form of tapetoretinal degeneration: fundus flavimaculatus. Trans. Am. Acad. Ophthalmol. Otolaryngol 69, 1048–1053.
Not in our library
88.
Franceschetti A, François J, 1965. [Fundus flavimaculatus]. Arch. Ophtalmol. Rev Gen. Ophtalmol 25, 505–530.
Not in our library
89.
François P, Turut P, Puech B, Hache JC, 1975. [Stargardťs disease and fundus flavimaculatus]. Arch. Ophtalmol. Rev Gen. Ophtalmol 35, 817–846.
Not in our library
90.
Fujinami K, Lois N, Mukherjee R, McBain VA, Tsunoda K, Tsubota K, Stone EM, Fitzke FW, Bunce C, Moore AT, Webster AR, Michaelides M, 2013a. A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations. Invest. Ophthalmol. Vis. Sci 54, 8181–8190.
Not in our library10.1167/iovs.13-12104
91.
Fujinami K, Sergouniotis PI, Davidson AE, Wright G, Chana RK, Tsunoda K, Tsubota K, Egan CA, Robson AG, Moore AT, Holder GE, Michaelides M, Webster AR, 2013b. Clinical and molecular analysis of Stargardt disease with preserved foveal structure and function. Am. J. Ophthalmol 156, 487–501 e481.
Not in our library10.1016/j.ajo.2013.05.003
92.
Clinical and Molecular Characteristics of Childhood-Onset Stargardt Disease · 2015
No notice
93.
Fujinami K, Strauss RW, Chiang JP, Audo IS, Bernstein PS, Birch DG, Bomotti SM, Cideciyan AV, Ervin AM, Marino MJ, Sahel JA, Mohand-Said S, Sunness JS, Traboulsi EI, West S, Wojciechowski R, Zrenner E, Michaelides M, Scholl HPN, ProgStar Study G, ProgStar Study G, 2019. Detailed genetic characteristics of an international large cohort of patients with Stargardt disease: ProgStar study report 8. Br. J. Ophthalmol 103, 390–397.
Not in our library10.1136/bjophthalmol-2018-312064
94.
Fukui T, Yamamoto S, Nakano K, Tsujikawa M, Morimura H, Nishida K, Ohguro N, Fujikado T, Irifune M, Kuniyoshi K, Okada AA, Hirakata A, Miyake Y, Tano Y, 2002. ABCA4 gene mutations in Japanese patients with Stargardt disease and retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci 43, 2819–2824.
Not in our library
95.
Garanto A, Chung DC, Duijkers L, Corral-Serrano JC, Messchaert M, Xiao R, Bennett J, Vandenberghe LH, Collin RW, 2016. In vitro and in vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery. Hum. Mol. Genet 25, 2552–2563.
Not in our library10.1093/hmg/ddw118
96.
Garanto A, Duijkers L, Tomkiewicz TZ, Collin RWJ, 2019. Antisense Oligonucleotide Screening to Optimize the Rescue of the Splicing Defect Caused by the Recurrent Deep-intronic ABCA4 Variant C.4539 + 2001 G> A in Stargardt Disease. Genes, Basel, pp. 10.
Not in our library10.3390/genes10060452
97.
Garg A, Lee W, Sengillo JD, Allikmets R, Garg K, Tsang SH, 2017. Peripapillary sparing in RDH12-associated Leber congenital amaurosis. Ophthalmic Genet 38, 575–579.
Not in our library10.1080/13816810.2017.1323339
98.
Gerard X, Perrault I, Hanein S, Silva E, Bigot K, Defoort-Delhemmes S, Rio M, Munnich A, Scherman D, Kaplan J, Kichler A, Rozet JM, 2012. AON-mediated exon skipping restores ciliation in fibroblasts harboring the common leber congenital amaurosis CEP290 mutation. Mol. Ther. Nucleic Acids 1, e29.
Not in our library10.1038/mtna.2012.21
99.
Gerber S, Rozet JM, Bonneau D, Souied E, Camuzat A, Dufier JL, Amalric P, Weissenbach J, Munnich A, Kaplan J, 1995. A gene for late-onset fundus flavimaculatus with macular dystrophy maps to chromosome 1p13. Am. J. Hum. Genet 56, 396–399.
Not in our library
100.
Giroux JM, Barbeau A, 1972. Erythrokeratodermia with ataxia. Arch. Dermatol 106, 183–188.
Not in our library
101.
Greenstein VC, Santos RA, Tsang SH, Smith RT, Barile GR, Seiple W, 2008. Preferred retinal locus in macular disease: characteristics and clinical implications. Retina 28, 1234–1240.
Not in our library10.1097/iae.0b013e31817c1b47
102.
Greenstein VC, Nunez J, Lee W, Schuerch K, Fortune B, Tsang SH, Allikmets R, Sparrow JR, Hood DC, 2017. A comparison of en face optical coherence tomography and fundus autofluorescence in stargardt disease. Invest. Ophthalmol. Vis. Sci 58, 5227–5236.
Not in our library10.1167/iovs.17-22532
103.
Guymer RH, Heon E, Lotery AJ, Munier FL, Schorderet DF, Baird PN, McNeil RJ, Haines H, Sheffield VC, Stone EM, 2001. Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. Arch. Ophthalmol 119, 745–751.
Not in our library10.1001/archopht.119.5.745
104.
Westeneng-van Haaften SC, Boon CJ, Cremers FP, Hoefsloot LH, den Hollander AI, Hoyng CB, 2012. Clinical and genetic characteristics of late-onset Stargardťs disease. Ophthalmology 119, 1199–1210.
Not in our library10.1016/j.ophtha.2012.01.005
105.
Han Z, Conley SM, Makkia RS, Cooper MJ, Naash MI, 2012. DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice. J. Clin. Invest 122, 3221–3226.
Not in our library10.1172/jci64833
106.
Hsu PD, Lander ES, Zhang F, 2014. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157, 1262–1278.
Not in our library10.1016/j.cell.2014.05.010
107.
Hu FY, Li JK, Gao FJ, Qi YH, Xu P, Zhang YJ, Wang DD, Wang LS, Li W, Wang M, Chen F, Shen SM, Xu GZ, Zhang SH, Chang Q, Wu JH, 2019. ABCA4 gene screening in a Chinese cohort with stargardt disease: identification of 37 novel variants. Front. Genet 10, 773.
Not in our library10.3389/fgene.2019.00773
108.
Huckfeldt RM, East JS, Stone EM, Sohn EH, 2016. Phenotypic variation in a family with pseudodominant stargardt disease. JAMA Ophthalmol 134, 580–583.
Not in our library10.1001/jamaophthalmol.2015.5471
109.
Jaakson K, Zernant J, Kulm M, Hutchinson A, Tonisson N, Glavac D, Ravnik-Glavac M, Hawlina M, Meltzer MR, Caruso RC, Testa F, Maugeri A, Hoyng CB, Gouras P, Simonelli F, Lewis RA, Lupski JR, Cremers FP, Allikmets R, 2003. Genotyping microarray (gene chip) for the ABCR (ABCA4) gene. Hum. Mutat 22, 395–403.
Not in our library10.1002/humu.10263
110.
Jacobson SG, Aleman TS, Cideciyan AV, Sumaroka A, Schwartz SB, Windsor EA, Traboulsi EI, Heon E, Pittler SJ, Milam AH, Maguire AM, Palczewski K, Stone EM, Bennett J, 2005. Identifying photoreceptors in blind eyes caused by RPE65 mutations: prerequisite for human gene therapy success. Proc. Natl. Acad. Sci. U. S. A 102, 6177–6182.
Not in our library10.1073/pnas.0500646102
111.
Jacobson SG, Aleman TS, Cideciyan AV, Roman AJ, Sumaroka A, Windsor EA, Schwartz SB, Heon E, Stone EM, 2009. Defining the residual vision in leber congenital amaurosis caused by RPE65 mutations. Invest. Ophthalmol. Vis. Sci 50, 2368–2375.
Not in our library10.1167/iovs.08-2696
112.
Jespersgaard C, Fang M, Bertelsen M, Dang X, Jensen H, Chen Y, Bech N, Dai L, Rosenberg T, Zhang J, Moller LB, Tumer Z, Brondum-Nielsen K, Gronskov K, 2019. Molecular genetic analysis using targeted NGS analysis of 677 individuals with retinal dystrophy. Sci. Rep 9, 1219.
Not in our library10.1038/s41598-018-38007-2
113.
Jiang F, Pan Z, Xu K, Tian L, Xie Y, Zhang X, Chen J, Dong B, Li Y, 2016. Screening of ABCA4 gene in a Chinese cohort with stargardt disease or cone-rod dystrophy with a report on 85 novel mutations. Invest. Ophthalmol. Vis. Sci 57, 145–152.
Not in our library10.1167/iovs.15-18190
114.
Julien S, Schraermeyer U, 2012. Lipofuscin can be eliminated from the retinal pigment epithelium of monkeys. Neurobiol. Aging 33, 2390–2397.
Not in our library10.1016/j.neurobiolaging.2011.12.009
115.
Jurgensmeier C, Bhosale P, Bernstein PS, 2007. Evaluation of 4-methylpyrazole as a potential therapeutic dark adaptation inhibitor. Curr. Eye Res 32, 911–915.
Not in our library10.1080/02713680701616156
116.
Kang Derwent JJ, Derlacki DJ, Hetling JR, Fishman GA, Birch DG, Grover S, Stone EM, Pepperberg DR, 2004. Dark adaptation of rod photoreceptors in normal subjects, and in patients with Stargardt disease and an ABCA4 mutation. Invest. Ophthalmol. Vis. Sci 45, 2447–2456.
Not in our library10.1167/iovs.03-1178
117.
Kaplan J, Gerber S, Larget-Piet D, Rozet JM, Dollfus H, Dufier JL, Odent S, Postel-Vinay A, Janin N, Briard ML,, 1993. A gene for Stargardťs disease (fundus flavimaculatus) maps to the short arm of chromosome 1. Nat. Genet 5, 308–311.
Not in our library10.1038/ng1193-308
118.
Keilhauer CN, Delori FC, 2006. Near-infrared autofluorescence imaging of the fundus: visualization of ocular melanin. Invest. Ophthalmol. Vis. Sci 47, 3556–3564.
Not in our library10.1167/iovs.06-0122
119.
Kellner S, Kellner U, Weber BH, Fiebig B, Weinitz S, Ruether K, 2009. Lipofuscin- and melanin-related fundus autofluorescence in patients with ABCA4-associated retinal dystrophies. Am. J. Ophthalmol 147, 895–902 902 e891.
Not in our library10.1016/j.ajo.2008.12.023
120.
Khan KN, Kasilian M, Mahroo OAR, Tanna P, Kalitzeos A, Robson AG, Tsunoda K, Iwata T, Moore AT, Fujinami K, Michaelides M, 2018. Early patterns of macular degeneration in ABCA4-associated retinopathy. Ophthalmology 125, 735–746.
Not in our library10.1016/j.ophtha.2017.11.020
121.
Khan M, Cornells SS, Khan MI, Elmelik D, Manders E, Bakker S, Derks R, Neveling K, van de Vorst M, Gilissen C, Meunier I, Defoort S, Puech B, Devos A, Schulz HL, Stohr H, Grassmann F, Weber BHF, Dhaenens CM, Cremers FPM, 2019. Cost-effective molecular inversion probe-based ABCA4 sequencing reveals deep-intronic variants in Stargardt disease. Hum. Mutat 40, 1749–1759.
Not in our library10.1002/humu.23787
122.
Khan M, Cornells SS, del Pozo-Valero M, Whelan L, Runhart EH, Mishra K, Bults F, AlSwaiti Y, AlTabishi A, De Baere E, Banff S, Banin E, Bauwens M, Ben-Yosef T, Boon CJF, van den Born LI, Defoort S, Devos A, Dockery A, Dudakova L, Fakin A, Farrar GJ, Ferraz Sallum JM, Fujinami K, Gilissen C, Glavac D, Gorin MB, Greenberg J, Hayashi T, Hettinga Y, Hoischen A, Hoyng CB, Hufendiek K, Jägle H, Kamakari S, Karali M, Kellner U, Klaver CCW, Kousal B, Lamey T, MacDonald IM, Matynia A, McLaren T, Mena MD, Meunier I, Miller R, Newman H, Ntozini B, Oldak M, Pieterse M, Podhajcer OL, Puech B, Ramesar R, Rüther K, Salameh M, Vallim Salles M, Sharon D, Simonelli F, Spital G, Steehouwer M, Szaflik JP, Thompson JA, Thuillier C, Tracewska AM, van Zweeden M, Vincent AL, Zanlonghi X, Liskova P, Stöhr H, De Roach J, Ayuso C, Roberts L, Weber BHF, Dhaenens C-M, Cremers FPM, 2020. Resolving the dark matter of ABCA4 for 1,054 Stargardt disease probands through integrated genomics and transcriptomics. Genet. Med https://www.nature.com/articles/s41436-020-0787-4#article-info.
Not in our library10.1038/s41436-020-0787-4
123.
Kim HJ, Sparrow JR, 2018. Novel bisretinoids of human retina are lyso alkyl ether glycerophosphoethanolamine-bearing A2PE species. J. Lipid Res 59, 1620–1629.
Not in our library10.1194/jlr.m084459
124.
Kjellstrom U, 2015. Reduced macular function in ABCA4 carriers. Mol. Vis 21, 767–782.
Not in our library
125.
Klein ML, Ferris FL 3rd, Francis PJ, Lindblad AS, Chew EY, Hamon SC, Ott J, 2010. Progression of geographic atrophy and genotype in age-related macular degeneration. Ophthalmology 117, 1554–1559.
Not in our library10.1016/j.ophtha.2009.12.012
126.
Klevering BJ, Blankenagel A, Maugeri A, Cremers FP, Hoyng CB, Rohrschneider K, 2002. Phenotypic spectrum of autosomal recessive cone-rod dystrophies caused by mutations in the ABCA4 (ABCR) gene. Invest. Ophthalmol. Vis. Sci 43, 1980–1985.
Not in our library
127.
Klien BA, Krill AE, 1967. Fundus flavimaculatus. Clinical, functional and histopathologic observations. Am. J. Ophthalmol 64, 3–23.
Not in our library
128.
Kniazeva M, Chiang MF, Morgan B, Anduze AL, Zack DJ, Han M, Zhang K, 1999. A new locus for autosomal dominant stargardt-like disease maps to chromosome 4. Am. J. Hum. Genet 64, 1394–1399.
Not in our library10.1086/302377
129.
Knudtson MD, Klein R, Klein BE, Lee KE, Meuer SM, Tomany SC, 2004. Location of lesions associated with age-related maculopathy over a 10-year period: the Beaver Dam Eye Study. Invest. Ophthalmol. Vis. Sci 45, 2135–2142.
Not in our library10.1167/iovs.03-1085
130.
Kong J, Kim SR, Binley K, Pata I, Doi K, Mannik J, Zernant-Rajang J, Kan O, Iqball S, Naylor S, Sparrow JR, Gouras P, Allikmets R, 2008. Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy. Gene Ther 15, 1311–1320.
Not in our library10.1038/gt.2008.78
131.
Kong X, Strauss RW, Michaelides M, Cideciyan AV, Sahel JA, Munoz B, West S, Scholl HP, ProgStar Study G, 2016. Visual acuity loss and associated risk factors in the retrospective progression of stargardt disease study (ProgStar report No. 2). Ophthalmology 123, 1887–1897.
Not in our library10.1016/j.ophtha.2016.05.027
132.
Kong X, Ho A, Munoz B, West S, Strauss RW, Jha A, Ervin A, Buzas J, Singh M, Hu Z, Cheetham J, Ip M, Scholl HPN, 2019. Reproducibility of measurements of retinal structural parameters using optical coherence tomography in stargardt disease. Transl Vis Sci Technol 8, 46.
Not in our library10.1167/tvst.8.3.46
133.
Krishnan AK, Bedell HE, 2018. Functional changes at the preferred retinal locus in subjects with bilateral central vision loss. Graefes Arch. Clin. Exp. Ophthalmol 256, 29–37.
Not in our library10.1007/s00417-017-3818-3
134.
Kubota R, Al-Fayoumi S, Mallikaarjun S, Patil S, Bavik C, Chandler JW, 2014. Phase 1, dose-ranging study of emixustat hydrochloride (ACU-4429), a novel visual cycle modulator, in healthy volunteers. Retina 34, 603–609.
Not in our library10.1097/01.iae.0000434565.80060.f8
135.
Kuniyoshi K, Terasaki H, Arai M, Hirose T, 2014. Multifocal electroretinograms in Stargardťs disease/fundus flavimaculatus. Ophthalmologica 232, 118–125.
Not in our library10.1159/000361056
136.
Lambertus S, van Huet RA, Bax NM, Hoefsloot LH, Cremers FP, Boon CJ, Klevering BJ, Hoyng CB, 2015. Early-onset stargardt disease: phenotypic and genotypic characteristics. Ophthalmology 122, 335–344.
Not in our library10.1016/j.ophtha.2014.08.032
137.
Lambertus S, Lindner M, Bax NM, Mauschitz MM, Nadal J, Schmid M, Schmitz-Valckenberg S, den Hollander AI, Weber BH, Holz FG, van der Wilt GJ, Fleckenstein M, Hoyng CB, Foveal sparing Atrophy Study, 2016. Progression of late-onset stargardt disease. T.. Invest. Ophthalmol. Vis. Sci 57, 5186–5191.
Not in our library10.1167/iovs.16-19833
138.
Lang W, 1885. Central choroiditis with disseminated patches in remainder of fundus. Trans. Ophthalmol. Soc. U. K 5, 140–141.
Not in our library
139.
Lee W, Noupuu K, Oll M, Duncker T, Burke T, Zernant J, Bearelly S, Tsang SH, Sparrow JR, Allikmets R, 2014. The external limiting membrane in early-onset Stargardt disease. Invest. Ophthalmol. Vis. Sci 55, 6139–6149.
Not in our library10.1167/iovs.14-15126
140.
Lee W, Xie Y, Zernant J, Yuan B, Bearelly S, Tsang SH, Lupski JR, Allikmets R, 2016. Complex inheritance of ABCA4 disease: four mutations in a family with multiple macular phenotypes. Hum. Genet 135, 9–19.
Not in our library10.1007/s00439-015-1605-y
141.
Lee W, Schuerch K, Zernant J, Collison FT, Bearelly S, Fishman GA, Tsang SH, Sparrow JR, Allikmets R, 2017. Genotypic spectrum and phenotype correlations of ABCA4-associated disease in patients of south Asian descent. Eur. J. Hum. Genet 25, 735–743.
Not in our library10.1038/ejhg.2017.13
142.
Lee W, Zernant J, Nagasaki T, Tsang SH, Allikmets R, 2018. Deep scleral exposure: a degenerative outcome of end-stage stargardt disease. Am. J. Ophthalmol 195, 16–25.
Not in our library10.1016/j.ajo.2018.07.018
143.
Lee W, Paavo M, Zernant J, Stong N, Laurente Z, Bearelly S, Nagasaki T, Tsang SH, Goldstein DB, Allikmets R, 2019. Modification of the PROM1 disease phenotype by a mutation in ABCA4. Ophthalmic Genet 40, 369–375.
Not in our library10.1080/13816810.2019.1660382
144.
Lenis TL, Hu J, Ng SY, Jiang Z, Sarfare S, Lloyd MB, Esposito NJ, Samuel W, Jaworski C, Bok D, Finnemann SC, Radeke MJ, Redmond TM, Travis GH, Radu RA, 2018. Expression of ABCA4 in the retinal pigment epithelium and its implications for Stargardt macular degeneration. Proc. Natl. Acad. Sci. U. S. A 115, El1120–El1127.
Not in our library10.1073/pnas.1802519115
145.
Lewis RA, Shroyer NF, Singh N, Allikmets R, Hutchinson A, Li Y, Lupski JR, Leppert M, Dean M, 1999. Genotype/Phenotype analysis of a photoreceptor-specific ATP-binding cassette transporter gene, ABCR, in Stargardt disease. Am. J. Hum. Genet 64, 422–434.
Not in our library10.1086/302251
146.
Lindblad AS, Lloyd PC, Clemons TE, Gensler GR, Ferris FL 3rd, Klein ML, Armstrong JR, Age-Related Eye Disease Study Research, 2009. Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. G. Arch. Ophthalmol 127, 1168–1174.
Not in our library10.1001/archophthalmol.2009.198
147.
Lindner M, Lambertus S, Mauschitz MM, Bax NM, Kersten E, Luning A, Nadal J, Schmitz-Valckenberg S, Schmid M, Holz FG, Hoyng CB, Fleckenstein M, Foveal sparing Atrophy Study, 2017. Differential disease progression in atrophic age-related macular degeneration and late-onset stargardt disease. T.. Invest. Ophthalmol. Vis. Sci 58, 1001–1007.
Not in our library10.1167/iovs.16-20980
148.
Liu Q, Sabirzhanova I, Bergbower EAS, Yanda M, Guggino WG, Cebotaru L, 2019. The CFTR corrector, VX-809 (lumacaftor), rescues ABCA4 trafficking mutants: a potential treatment for stargardt disease. Cell. Physiol. Biochem 53, 400–412.
Not in our library10.33594/000000146
149.
Lois N, Holder GE, Bunce C, Fitzke FW, Bird AC, 2001. Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch. Ophthalmol 119, 359–369.
Not in our library10.1001/archopht.119.3.359
150.
Lois N, Halfyard AS, Bird AC, Holder GE, Fitzke FW, 2004. Fundus autofluorescence in Stargardt macular dystrophy-fundus flavimaculatus. Am. J. Ophthalmol 138, 55–63.
Not in our library10.1016/j.ajo.2004.02.056
151.
Lopez PF, Maumenee IH, de la Cruz Z, Green WR, 1990. Autosomal-dominant fundus flavimaculatus. Clinicopathologic correlation. Ophthalmology 97, 798–809.
Not in our library10.1016/s0161-6420(90)32508-3
152.
Lopez-Rubio S, Chacon-Camacho OF, Matsui R, Guadarrama-Vallejo D, Astiazaran MC, Zenteno JC, 2018. Retinal phenotypic characterization of patients with ABCA4 retinopathydue to the homozygous p.Alal773Val mutation. Mol. Vis 24, 105–114.
Not in our library
153.
Ma CJ, Lee W, Stong N, Zernant J, Chang S, Goldstein D, Nagasaki T, Allikmets R, 2019. Late-onset pattern macular dystrophy mimicking ABGA4 and PRPH2 disease is caused by a homozygous frameshift mutation in ROM1. Cold Spring Harb Mol Case Stud 5.
Not in our library10.1101/mcs.a003624
154.
MacDonald IM, Sieving PA, 2018. Investigation of the effect of dietary docosahexaenoic acid (DHA) supplementation on macular function in subjects with autosomal recessive Stargardt macular dystrophy. Ophthalmic Genet 39, 477–486.
Not in our library10.1080/13816810.2018.1484931
155.
Maeda A, Maeda T, Golczak M, Palczewski K, 2008. Retinopathy in mice induced by disrupted all-trans-retinal clearance. J. Biol. Chem 283, 26684–26693.
Not in our library10.1074/jbc.m804505200
156.
Maguire AM, Russell S, Wellman JA, Chung DC, Yu ZF, Tillman A, Wittes J, Pappas J, Elci O, Marshall KA, McCague S, Reichert H, Davis M, Simonelli F, Leroy BP, Wright JF, High KA, Bennett J, 2019. Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: results of phase 1 and 3 trials. Ophthalmology 126, 1273–1285.
Not in our library10.1016/j.ophtha.2019.06.017
157.
Maia-Lopes S, Silva ED, Silva MF, Reis A, Faria P, Castelo-Branco M, 2008. Evidence of widespread retinal dysfunction in patients with stargardt disease and morphologically unaffected carrier relatives. Invest. Ophthalmol. Vis. Sci 49, 1191–1199.
Not in our library10.1167/iovs.07-1051
158.
Makelainen S, Godia M, Hellsand M, Viluma A, Hahn D, Makdoumi K, Zeiss CJ, Mellersh C, Ricketts SL, Narfstrom K, Hallbook F, Ekesten B, Andersson G, Bergstrom TF, 2019. An ABCA4 loss-of-function mutation causes a canine form of Stargardt disease. PLoS Genet 15, e1007873.
Not in our library10.1371/journal.pgen.1007873
159.
Martinez-Mir A, Paloma E, Allikmets R, Ayuso C, del Rio T, Dean M, Vilageliu L, Gonzalez-Duarte R, Balcells S, 1998. Retinitis pigmentosa caused by a homozygous mutation in the Stargardt disease gene ABCR. Nat. Genet 18, 11–12.
Not in our library10.1038/ng0198-11
160.
Mata NL, Tzekov RT, Liu X, Weng J, Birch DG, Travis GH, 2001. Delayed dark-adaptation and lipofuscin accumulation in abcr + /− mice: implications for involvement of ABCR In age-related macular degeneration. Invest. Ophthalmol. Vis. Sci 42, 1685–1690.
Not in our library
161.
Maugeri A, van Driel MA, van de Pol DJ, Klevering BJ, van Haren FJ, Tijmes N, Bergen AA, Rohrschneider K, Blankenagel A, Pinckers AJ, Dahl N, Brunner HG, Deutman AF, Hoyng CB, Cremers FP, 1999. The 2588G->C mutation in the ABCR gene is a mild frequent founder mutation in the Western European population and allows the classification of ABCR mutations in patients with Stargardt disease. Am. J. Hum. Genet 64, 1024–1035.
Not in our library10.1086/302323
162.
Maugeri A, Klevering BJ, Rohrschneider K, Blankenagel A, Brunner HG, Deutman AF, Hoyng CB, Cremers FP, 2000. Mutations in the ABCA4 (ABCR) gene are the major cause of autosomal recessive cone-rod dystrophy. Am. J. Hum. Genet 67, 960–966.
Not in our library10.1086/303079
163.
Maugeri A, Flothmann K, Hemmrich N, Ingvast S, Jorge P, Paloma E, Patel R, Rozet JM, Tammur J, Testa F, Balcells S, Bird AC, Brunner HG, Hoyng CB, Metspalu A, Simonelli F, Allikmets R, Bhattacharya SS, D’Urso M, Gonzalez-Duarte R, Kaplan J, te Meerman GJ, Santos R, Schwartz M, Van Camp G, Wadelius C, Weber BH, Cremers FP, 2002. The ABCA4 2588G>C Stargardt mutation: single origin and increasing frequency from South-West to North-East Europe. Eur. J. Hum. Genet 10, 197–203.
Not in our library10.1038/sj.ejhg.5200784
164.
Maw MA, Corbeil D, Koch J, Hellwig A, Wilson-Wheeler JC, Bridges RJ, Kumaramanickavel G, John S, Nancarrow D, Roper K, Weigmann A, Huttner WB, Denton MJ, 2000. A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration. Hum. Mol. Genet 9, 27–34.
Not in our library10.1093/hmg/9.1.27
165.
McBain VA, Townend J, Lois N, 2012. Progression of retinal pigment epithelial atrophy in stargardt disease. Am. J. Ophthalmol 154, 146–154.
Not in our library10.1016/j.ajo.2012.01.019
166.
McClements ME, Barnard AR, Singh MS, Charbel Issa P, Jiang Z, Radu RA, MacLaren RE, 2019. An AAV dual vector strategy ameliorates the stargardt phenotype in adult Abca4(-/-) mice. Hum. Gene Ther 30, 590–600.
Not in our library10.1089/hum.2018.156
167.
Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in Macular Degeneration · 2018
No notice
168.
Melillo P, Testa F, Rossi S, Di Iorio V, Orrico A, Auricchio A, Simonelli F, 2016. En face spectral-domain optical coherence tomography for the monitoring of lesion area progression in stargardt disease. Invest. Ophthalmol. Vis. Sci 57, OCT247–252.
Not in our library10.1167/iovs.15-18751
169.
Michaelides M, Holder GE, Bradshaw K, Hunt DM, Moore AT, 2005. Cone-rod dystrophy, intrafamilial variability, and incomplete penetrance associated with the R172W mutation in the peripherin/RDS gene. Ophthalmology 112, 1592–1598.
Not in our library10.1016/j.ophtha.2005.04.004
170.
Molday RS, 2015. Insights into the molecular properties of ABCA4 and its role in the visual cycle and stargardt disease. Prog Mol Biol Transl Sci 134, 415–431.
Not in our library10.1016/bs.pmbts.2015.06.008
171.
Molday LL, Molday Rs AR, 2016. Localization and Functional Analysis of ABCA4 Variants Associated with Stargardt Disease, Association for Research in Vision and Ophthalmology. Seattle, WA.
Not in our library
172.
Molday LL, Wahl D, Sarunic MV, Molday RS, 2018. Localization and functional characterization of the p.Asn965Ser (N965S) ABCA4 variant in mice reveal pathogenic mechanisms underlying Stargardt macular degeneration. Hum. Mol. Genet 27, 295–306.
Not in our library10.1093/hmg/ddx400
173.
Muller PL, Gliem M, Mangold E, Bolz HJ, Finger RP, McGuinness M, Betz C, Jiang Z, Weber BH, MacLaren RE, Holz FG, Radu RA, Charbel Issa P, 2015. Monoallelic ABGA4 mutations appear insufficient to cause retinopathy: a quantitative auto fluorescence study. Invest. Ophthalmol. Vis. Sci 56, 8179–8186.
Not in our library10.1167/iovs.15-17629
174.
Muller PL, Fimmers R, Gliem M, Holz FG, Charbel Issa P, 2017. Choroidal alterations in abca4-related retinopathy. Retina 37, 359–367.
Not in our library10.1097/iae.0000000000001169
175.
Nakao T, Tsujikawa M, Sawa M, Gomi F, Nishida K, 2012. Foveal sparing in patients with Japanese Stargard’s disease and good visual acuity. Jpn. J. Ophthalmol 56, 584–588.
Not in our library10.1007/s10384-012-0172-1
176.
Nassisi M, Mohand-Said S, Andrieu C, Antonio A, Condroyer C, Mejecase C, Varin J, Wohlschlegel J, Dhaenens CM, Sahel JA, Zeitz C, Audo I, 2019. Prevalence of ABCA4 deep-intronic variants and related phenotype in an unsolved “One-Hit” cohort with stargardt disease. Int. J. Mol. Sci 20, E5053.
Not in our library10.3390/ijms20205053
177.
Noupuu K, Lee W, Zernant J, Tsang SH, Allikmets R, 2014. Structural and genetic assessment of the ABCA4-associated optical gap phenotype. Invest. Ophthalmol. Vis. Sci 55, 7217–7226.
Not in our library10.1167/iovs.14-14674
178.
Noupuu K, Lee W, Zernant J, Greenstein VC, Tsang S, Allikmets R, 2016. Recessive Stargardt disease phenocopying hydroxychloroquine retinopathy. Graefes Arch. Clin. Exp. Ophthalmol 254, 865–872.
Not in our library10.1007/s00417-015-3142-8
179.
Oner A, Gonen ZB, Sevim DG, Smim Kahraman N, Unlu M, 2018. Suprachoroidal adipose tissue-derived mesenchymal stem cell implantation in patients with dry-type Age-related macular degeneration and stargardťs macular dystrophy: 6-month follow-up results of a phase 2 study. Cell. Reprogr 20, 329–336.
Not in our library10.1089/cell.2018.0045
180.
Paavo M, Zhao J, Kim HJ, Lee W, Zernant J, Cai C, Allikmets R, Tsang SH, Sparrow JR, 2018. Mutations in gpr143/OA1 and ABCA4 inform interpretations of short-wavelength and near-infrared fundus auto fluorescence. Invest. Ophthalmol. Vis. Sci 59, 2459–2469.
Not in our library10.1167/iovs.18-24213
181.
Paavo M, Lee W, Allikmets R, Tsang S, Sparrow JR, 2019. Photoreceptor cells as a source of fundus autofluorescence in recessive Stargardt disease. J. Neurosci. Res 97, 98–106.
Not in our library10.1002/jnr.24252
182.
Pang CE, Suqin Y, Sherman J, Freund KB, 2015. New insights into Stargardt disease with multimodal imaging. Ophthalmic Surg Lasers Imaging Retina 46, 257–261.
Not in our library10.3928/23258160-20150213-09
183.
Papermaster DS, Converse CA, Zorn M, 1976. Biosynthetic and immunochemical characterization of large protein in frog and cattle rod outer segment membranes. Exp. Eye Res 23, 105–115.
Not in our library10.1016/0014-4835(76)90194-9
184.
Identification and Correction of Mechanisms Underlying Inherited Blindness in Human iPSC-Derived Optic Cups · 2016
No notice
185.
Parish CA, Hashimoto M, Nakanishi K, Dillon J, Sparrow J, 1998. Isolation and one-step preparation of A2E and iso-A2E, fluorophores from human retinal pigment epithelium. Proc. Natl. Acad. Sci. U. S. A 95, 14609–14613.
Not in our library10.1073/pnas.95.25.14609
186.
Park JC, Collison FT, Fishman GA, Allikmets R, Zernant J, Liu M, McAnany JJ, 2015. Objective analysis of hyperreflective outer retinal bands imaged by optical coherence tomography in patients with stargardt disease. Invest. Ophthalmol. Vis. Sci 56, 4662–4667.
Not in our library10.1167/iovs.15-16955
187.
Parker MA, Choi D, Erker LR, Pennesi ME, Yang P, Chegarnov EN, Steinkamp PN, Schlechter CL, Dhaenens CM, Mohand-Said S, Audo I, Sahel J, Weleber RG, Wilson DJ, 2016. Test-retest variability of functional and structural parameters in patients with stargardt disease participating in the SAR422459 gene therapy trial. Transl Vis Sci Technol 5, 10.
Not in our library10.1167/tvst.5.5.10
188.
Parodi MB, Iacono P, Triolo G, La Spina C, Zucchiatti I, Cicinelli MV, Borrelli E, Manitto MP, Martina E, Bandello F, 2015. Morpho-functional correlation of fundus autofluorescence in Stargardt disease. Br. J. Ophthalmol 99, 1354–1359.
Not in our library10.1136/bjophthalmol-2014-306237
189.
Passerini I, Sodi A, Giambene B, Mariottini A, Menchini U, Torricelli F, 2010. Novel mutations in of the ABCR gene in Italian patients with Stargardt disease. Eye 24, 158–164.
Not in our library10.1038/eye.2009.35
190.
Pellegrini M, Acquistapace A, Oldani M, Cereda MG, Giani A, Cozzi M, Staurenghi G, 2016. Dark atrophy: an optical coherence tomography angiography study. Ophthalmology 123, 1879–1886.
Not in our library10.1016/j.ophtha.2016.05.041
191.
Piccardi M, Fadda A, Martelli F, Marangoni D, Magli A, Minnella AM, Bertelli M, Di Marco S, Bisti S, Falsini B, 2019. Antioxidant saffron and central retinal function in ABCA4-related stargardt macular dystrophy. Nutrients 11.
Not in our library10.3390/nu11102461
192.
Quazi F, Molday RS, 2013. Differential phospholipid substrates and directional transport by ATP-binding cassette proteins ABCA1, ABCA7, and ABCA4 and disease-causing mutants. J. Biol. Chem 288, 34414–34426.
Not in our library10.1074/jbc.m113.508812
193.
Quazi F, Molday RS, 2014. ATP-binding cassette transporter ABCA4 and chemical isomerization protect photoreceptor cells from the toxic accumulation of excess 11-cis-retinal. Proc. Natl. Acad. Sci. U. S. A Ill, 5024–5029.
Not in our library10.1073/pnas.1400780111
194.
Quazi F, Lenevich S, Molday RS, 2012. ABCA4 is an N-retinylidene-phosphatidy-lethanolamine and phosphatidylethanolamine importer. Nat. Commun 3, 925.
Not in our library10.1038/ncomms1927
195.
Querques G, Leveziel N, Benhamou N, Voigt M, Soubrane G, Souied EH, 2006. Analysis of retinal flecks in fundus flavimaculatus using optical coherence tomography. Br. J. Ophthalmol 90, 1157–1162.
Not in our library10.1136/bjo.2006.094136
196.
Querques G, Prato R, Iaculli C, Voigt M, Delle Noci N, Coscas G, Soubrane G, Souied EH, 2008. Correlation of visual function impairment and OCT findings in patients with Stargardt disease and fundus flavimaculatus. Eur. J. Ophthalmol 18, 239–247.
Not in our library10.1177/112067210801800212
197.
Racz B, Varadi A, Kong J, Allikmets R, Pearson PG, Johnson G, Cioffi CL, Petrukhin K, 2018. A non-retinoid antagonist of retinol-binding protein 4 rescues phenotype in a model of Stargardt disease without inhibiting the visual cycle. J. Biol. Chem 293, 11574–11588.
Not in our library10.1074/jbc.ra118.002062
198.
Rees HA, Liu DR, 2018. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat. Rev. Genet 19, 770–788.
Not in our library10.1038/s41576-018-0059-1
199.
Riveiro-Alvarez R, Valverde D, Lorda-Sanchez I, Trujillo-Tiebas MJ, Cantalapiedra D, Vallespin E, Aguirre-Lamban J, Ramos C, Ayuso C, 2007. Partial paternal uniparental disomy (UPD) of chromosome 1 in a patient with Stargardt disease. Mol. Vis 13, 96–101.
Not in our library
200.
Riveiro-Alvarez R, Lopez-Martinez MA, Zernant J, Aguirre-Lamban J, Cantalapiedra D, Avila-Fernandez A, Gimenez A, Lopez-Molina MI, Garcia-Sandoval B, Bianco-Kelly F, Corton M, Tatu S, Fernandez-San Jose P, Trujillo-Tiebas MJ, Ramos C, Allikmets R, Ayuso C, 2013. Outcome of ABCA4 disease-associated alleles in autosomal recessive retinal dystrophies: retrospective analysis in 420 Spanish families. Ophthalmology 120, 2332–2337.
Not in our library10.1016/j.ophtha.2013.04.002
201.
Rivera A, White K, Stohr H, Steiner K, Hemmrich N, Grimm T, Jurklies B, Lorenz B, Scholl HP, Apfelstedt-Sylla E, Weber BH, 2000. A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration. Am. J. Hum. Genet 67, 800–813.
Not in our library10.1086/303090
202.
Rosenberg T, Klie F, Garred P, Schwartz M, 2007. N965S is a common ABCA4 variant in Stargardt-related retinopathies in the Danish population. Mol. Vis 13, 1962–1969.
Not in our library
203.
Rotenstreich Y, Fishman GA, Anderson RJ, 2003. Visual acuity loss and clinical observations in a large series of patients with Stargardt disease. Ophthalmology 110, 1151–1158.
Not in our library10.1016/s0161-6420(03)00333-6
204.
Rozet JM, Gerber S, Ghazi I, Perrault I, Ducroq D, Souied E, Cabot A, Dufier JL, Munnich A, Kaplan J, 1999. Mutations of the retinal specific ATP binding transporter gene (ABCR) in a single family segregating both autosomal recessive retinitis pigmentosa RP19 and Stargardt disease: evidence of clinical heterogeneity at this locus. J. Med. Genet 36, 447–451.
Not in our library
205.
Runhart EH, Sangermano R, Cornells SS, Verheij J, Plomp AS, Boon CJF, Lugtenberg D, Roosing S, Bax NM, Blokland EAW, Jacobs-Camps MHM, van der Velde-Visser SD, Pott JR, Rohrschneider K, Thiadens A, Klaver CCW, van den Born LI, Hoyng CB, Cremers FPM, 2018. The common ABCA4 variant p.Asnl868Ile shows nonpenetrance and variable expression of stargardt disease when present in trans with severe variants. Invest. Ophthalmol. Vis. Sci 59, 3220–3231.
Not in our library10.1167/iovs.18-23881
206.
Runhart EH, Valkenburg D, Cornells SS, Khan M, Sangermano R, Albert S, Bax NM, Astuti GDN, Gilissen C, Pott JR, Verheij J, Blokland EAW, Cremers FPM, van den Born LI, Hoyng CB, 2019. Late-onset stargardt disease due to mild, deep-intronic ABCA4 alleles. Invest. Ophthalmol. Vis. Sci 60, 4249–4256.
Not in our library10.1167/iovs.19-27524
207.
Sabirzhanova I, Lopes Pacheco M, Rapino D, Grover R, Handa JT, Guggino WB, Cebotaru L, 2015. Rescuing trafficking mutants of the ATP-binding cassette protein, ABCA4, with small molecule correctors as a treatment for stargardt eye disease. J. Biol. Chem 290, 19743–19755.
Not in our library10.1074/jbc.m115.647685
208.
Sachdeva MM, Eliott D, 2016. Stem cell-based therapy for diseases of the retinal pigment epithelium: from bench to bedside. Semin. Ophthalmol 31, 25–29.
Not in our library10.3109/08820538.2015.1115253
209.
Salvatore S, Fishman GA, McAnany JJ, Genead MA, 2014. Association of dark-adapted visual function with retinal structural changes in patients with Stargardt disease. Retina 34, 989–995.
Not in our library10.1097/iae.0000000000000022
210.
Sangermano R, Bax NM, Bauwens M, van den Born LI, De Baere E, Garanto A, Collin RW, Goercharn-Ramlal AS, den Engelsman-van Dijk AH, Rohrschneider K, Hoyng CB, Cremers FP, Albert S, 2016. Photoreceptor progenitor mRNA analysis reveals exon skipping resulting from the ABCA4 c.5461–10T> C mutation in Stargardt disease. Ophthalmology 123, 1375–1385.
Not in our library10.1016/j.ophtha.2016.01.053
211.
Sangermano R, Khan M, Cornells SS, Richelle V, Albert S, Garanto A, Elmelik D, Qamar R, Lugtenberg D, van den Born LI, Collin RWJ, Cremers FPM, 2018. ABCA4 midigenes reveal the full splice spectrum of all reported noncanonical splice site variants in Stargardt disease. Genome Res 28, 100–110.
Not in our library10.1101/gr.226621.117
212.
Deep-intronic ABCA4 variants explain missing heritability in Stargardt disease and allow correction of splice defects by antisense oligonucleotides · 2019
No notice
213.
Scholl HP, Besch D, Vonthein R, Weber BH, Apfelstedt-Sylla E, 2002. Alterations of slow and fast rod ERG signals in patients with molecularly confirmed Stargardt disease type 1. Invest. Ophthalmol. Vis. Sci 43, 1248–1256.
Not in our library
214.
Schonbach EM, Ibrahim MA, Strauss RW, Birch DG, Cideciyan AV, Hahn GA, Ho A, Kong X, Nasser F, Sunness JS, Zrenner E, Sadda SR, West SK, Scholl HPN, Progression of Stargardt Disease Study, 2017a. Fixation location and stability using the MP-1 microperimeter in stargardt disease: ProgStar report No. 3. G. Ophthalmol Retina 1, 68–76.
Not in our library10.1016/j.oret.2016.08.009
215.
Schonbach EM, Wolfson Y, Strauss RW, Ibrahim MA, Kong X, Munoz B, Birch DG, Cideciyan AV, Hahn GA, Nittala M, Sunness JS, Sadda SR, West SK, Scholl HPN, ProgStar Study G, 2017b. Macular Sensitivity Measured with Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7. JAMA Ophthalmol 135. pp. 696–703.
Not in our library10.1001/jamaophthalmol.2017.1162
216.
Schonbach EM, Strauss RW, Kong X, Munoz B, Ibrahim MA, Sunness JS, Birch DG, Hahn GA, Nasser F, Zrenner E, Sadda SR, West SK, Scholl HPN, ProgStar Study G, 2018. Longitudinal changes of fixation location and stability within 12 Months in stargardt disease: ProgStar report No. 12. Am. J. Ophthalmol 193, 54–61.
Not in our library10.1016/j.ajo.2018.06.003
217.
Schorderet DF, Iouranova A, Favez T, Tiab L, Escher P, 2013. IROme, a new high-throughput molecular tool for the diagnosis of inherited retinal dystrophies. BioMed Res. Int 2013, 198089.
Not in our library10.1155/2013/198089
218.
Schulz HL, Grassmann F, Kellner U, Spital G, Ruther K, Jagle H, Hufendiek K, Rating P, Huchzermeyer C, Baier MJ, Weber BH, Stohr H, 2017. Mutation spectrum of the ABCA4 gene in 335 stargardt disease patients from a multicenter German cohort-impact of selected deep intronic variants and common SNPs. Invest. Ophthalmol. Vis. Sci 58, 394–403.
Not in our library10.1167/iovs.16-19936
219.
Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, Mickunas E, Gay R, Klimanskaya I, Lanza R, 2012. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379, 713–720.
Not in our library10.1016/s0140-6736(12)60028-2
220.
Schwartz SD, Regillo CD, Lam BL, Eliott D, Rosenfeld PJ, Gregori NZ, Hubschman JP, Davis JL, Heilwell G, Spirn M, Maguire J, Gay R, Bateman J, Ostrick RM, Morris D, Vincent M, Anglade E, Del Priore LV, Lanza R, 2015. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardťs macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet 385, 509–516.
Not in our library10.1016/s0140-6736(14)61376-3
221.
Sciezynska A, Ozieblo D, Ambroziak AM, Korwin M, Szulborski K, Krawczynski M, Stawinski P, Szaflik J, Szaflik JP, Ploski R, Oldak M, 2016. Next-generation sequencing of ABCA4: high frequency of complex alleles and novel mutations in patients with retinal dystrophies from Central Europe. Exp. Eye Res 145, 93–99.
Not in our library10.1016/j.exer.2015.11.011
222.
Shankar SP, Hughbanks-Wheaton DK, Birch DG, Sullivan LS, Conneely KN, Bowne SJ, Stone EM, Daiger SP, 2016. Autosomal dominant retinal dystrophies caused by a founder splice site mutation, C.828 + 3A>T, in PRPH2 and protein haplotypes in trans as modifiers. Invest. Ophthalmol. Vis. Sci 57, 349–359.
Not in our library10.1167/iovs.15-16965
223.
Sharon D, Ben-Yosef T, Goldenberg-Cohen N, Pras E, Gradstein L, Soudry S, Mezer E, Zur D, Abbasi AH, Zeitz C, Cremers FPM, Khan MI, Levy J, Rotenstreich Y, Birk OS, Ehrenberg M, Leibu R, Newman H, Shomron N, Banin E, Perlman I, 2020. A nationwide genetic analysis of inherited retinal diseases in Israel as assessed by the Israeli inherited retinal disease consortium (IIRDC). Hum. Mutat 41, 140–149.
Not in our library10.1002/humu.23903
224.
Shroyer NF, Lewis RA, Lupski JR, 2000. Complex inheritance of ABCR mutations in Stargardt disease: linkage disequilibrium, complex alleles, and pseudodominance. Hum. Genet 106, 244–248.
Not in our library10.1007/s004390051034
225.
Shroyer NF, Lewis RA, Lupski JR, 2001a. Analysis of the ABCR (ABCA4) gene in 4-aminoquinoline retinopathy: is retinal toxicity by chloroquine and hydroxychloroquine related to Stargardt disease? Am. J. Ophthalmol 131, 761–766.
Not in our library10.1016/s0002-9394(01)00838-8
226.
Shroyer NF, Lewis RA, Yatsenko AN, Lupski JR, 2001b. Null missense ABCR (ABCA4) mutations in a family with stargardt disease and retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci 42, 2757–2761.
Not in our library
227.
Simon WA, Herrmann M, Klein T, Shin JM, Huber R, Senn-Bilfinger J, Postius S, 2007. Soraprazan: setting new standards in inhibition of gastric acid secretion. J. Pharmacol. Exp. Therapeut 321, 866–874.
Not in our library10.1124/jpet.107.120428
228.
Sisk RA, Leng T, 2014. Multimodal imaging and multifocal electroretinography demonstrate autosomal recessive Stargardt disease may present like occult macular dystrophy. Retina 34, 1567–1575.
Not in our library10.1097/iae.0000000000000136
229.
Sodi A, Mucciolo DP, Cipollini F, Murro V, Caporossi O, Virgili G, Rizzo S, 2016. En face OCT in Stargardt disease. Graefes Arch. Clin. Exp. Ophthalmol 254, 1669–1679.
Not in our library10.1007/s00417-015-3254-1
230.
Sohocki MM, Sullivan LS, Mintz-Hittner HA, Birch D, Heckenlively JR, Freund CL, McInnes RR, Daiger SP, 1998. A range of clinical phenotypes associated with mutations in CRX, a photoreceptor transcription-factor gene. Am. J. Hum. Genet 63, 1307–1315.
Not in our library10.1086/302101
231.
Song H, Rossi EA, Latchney L, Bessette A, Stone E, Hunter JJ, Williams DR, Chung M, 2015a. Cone and rod loss in Stargardt disease revealed by adaptive optics scanning light ophthalmoscopy. JAMA Ophthalmol 133, 1198–1203.
Not in our library10.1001/jamaophthalmol.2015.2443
232.
Treatment of Macular Degeneration Using Embryonic Stem Cell-Derived Retinal Pigment Epithelium: Preliminary Results in Asian Patients · 2015
No notice
233.
Souied EH, Ducroq D, Gerber S, Ghazi I, Rozet JM, Perrault I, Munnich A, Dufier JL, Coscas G, Soubrane G, Kaplan J, 1999. Age-related macular degeneration in grandparents of patients with Stargardt disease: genetic study. Am. J. Ophthalmol 128, 173–178.
Not in our library10.1016/s0002-9394(99)00145-2
234.
Sparrow JR, Boulton M, 2005. RPE lipofuscin and its role in retinal pathobiology. Exp. Eye Res 80, 595–606.
Not in our library10.1016/j.exer.2005.01.007
235.
Sparrow JR, Yamamoto K, 2012. The bisretinoids of RPE lipofuscin: a complex mixture. Adv. Exp. Med. Biol 723, 761–767.
Not in our library10.1007/978-1-4614-0631-0_97
236.
Sparrow JR, Hicks D, Hamel CP, 2010. The retinal pigment epithelium in health and disease. Curr. Mol. Med 10, 802–823.
Not in our library10.2174/156652410793937813
237.
Sparrow JR, Gregory-Roberts E, Yamamoto K, Blonska A, Ghosh SK, Ueda K, Zhou J, 2012. The bisretinoids of retinal pigment epithelium. Prog. Retin. Eye Res 31, 121–135.
Not in our library10.1016/j.preteyeres.2011.12.001
238.
Sparrow JR, Blonska A, Flynn E, Duncker T, Greenberg JP, Secondi R, Ueda K, Delori FC, 2013. Quantitative fundus autofluorescence in mice: correlation with HPLC quantitation of RPE lipofuscin and measurement of retina outer nuclear layer thickness. Invest. Ophthalmol. Vis. Sci 54, 2812–2820.
Not in our library10.1167/iovs.12-11490
239.
Sparrow JR, Marsiglia M, Allikmets R, Tsang S, Lee W, Duncker T, Zernant J, 2015. Flecks in recessive stargardt disease: short-wavelength Autofluorescence, near-infrared autofluorescence, and optical coherence tomography. Invest. Ophthalmol. Vis. Sci 56, 5029–5039.
Not in our library10.1167/iovs.15-16763
240.
Sparrow JR, Duncker T, Schuerch K, Paavo M, de Carvalho JRL Jr., 2020. Lessons learned from quantitative fundus autofluorescence. Prog. Retin. Eye Res 74,100774.
Not in our library10.1016/j.preteyeres.2019.100774
241.
Stargardt K, 1909. Über familiäre, progressive Degeneration in der Maculagegend des Auges. Albrecht von Graefes Arch Klin Ophthalmology 71, 534–550.
Not in our library
242.
Steinberg RH, Wood I, Hogan MJ, 1977. Pigment epithelial ensheathment and phagocytosis of extrafoveal cones in human retina. Philos. Trans. R. Soc. Lond. B Biol. Sci 277, 459–474.
Not in our library10.1098/rstb.1977.0028
243.
Stenirri S, Battistella S, Fermo I, Manitto MP, Martina E, Brancato R, Ferrari M, Cremonesi L, 2006. De novo deletion removes a conserved motif in the C-terminus of ABCA4 and results in cone-rod dystrophy. Clin. Chem. Lab. Med 44, 533–537.
Not in our library10.1515/cclm.2006.116
244.
Stone EM, Nichols BE, Kimura AE, Weingeist TA, Drack A, Sheffield VC, 1994. Clinical features of a Stargardt-like dominant progressive macular dystrophy with genetic linkage to chromosome 6q. Arch. Ophthalmol 112, 765–772.
Not in our library10.1001/archopht.1994.01090180063036
245.
Strauss RW, Ho A, Munoz B, Cideciyan AV, Sahel JA, Sunness JS, Birch DG, Bernstein PS, Michaelides M, Traboulsi EI, Zrenner E, Sadda S, Ervin AM, West S, Scholl HP, Progression of Stargardt Disease Study, G., 2016. The natural history of the progression of atrophy secondary to stargardt disease (ProgStar) studies: design and baseline characteristics: ProgStar report No. 1. Ophthalmology 123, 817–828.
Not in our library10.1016/j.ophtha.2015.12.009
246.
Strauss RW, Munoz B, Ho A, Jha A, Michaelides M, Cideciyan AV, Audo I, Birch DG, Hariri AH, Nittala MG, Sadda S, West S, Scholl HPN, ProgStar Study G, 2017a. Progression of stargardt disease as determined by fundus autofluorescence in the retrospective progression of stargardt disease study (ProgStar report No. 9). JAMA Ophthalmol 135, 1232–1241.
Not in our library10.1001/jamaophthalmol.2017.4152
247.
Strauss RW, Munoz B, Ho A, Jha A, Michaelides M, Mohand-Said S, Cideciyan AV, Birch D, Hariri AH, Nittala MG, Sadda S, Scholl HPN, ProgStar Study G, 2017b. Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5. JAMA Ophthalmol 135, 687–695.
Not in our library10.1001/jamaophthalmol.2017.1121
248.
Sun H, Molday RS, Nathans J, 1999. Retinal stimulates ATP hydrolysis by purified and reconstituted ABCR, the photoreceptor-specific ATP-binding cassette transporter responsible for Stargardt disease. J. Biol. Chem 274, 8269–8281.
Not in our library10.1074/jbc.274.12.8269
249.
Sunness JS, Steiner JN, 2008. Retinal function and loss of autofluorescence in stargardt disease. Retina 28, 794–800.
Not in our library10.1097/iae.0b013e31816690bd
250.
Sunness JS, Ziegler MD, Applegate CA, 2006. Issues in quantifying atrophic macular disease using retinal autofluorescence. Retina 26, 666–672.
Not in our library10.1097/01.iae.0000236472.56195.e9
251.
Tanaka K, Lee W, Zernant J, Schuerch K, Ciccone L, Tsang SH, Sparrow JR, Allikmets R, 2018. The rapid-onset chorioretinopathy phenotype of ABCA4 disease. Ophthalmology 125, 89–99.
Not in our library10.1016/j.ophtha.2017.07.019
252.
Tanna P, Georgiou M, Strauss RW, Ali N, Kumaran N, Kalitzeos A, Fujinami K, Michaelides M, 2019. Cross-sectional and longitudinal assessment of the ellipsoid zone in childhood-onset stargardt disease. Transl Vis Sci Technol 8, 1.
Not in our library10.1167/tvst.8.2.1
253.
Testa F, Rossi S, Sodi A, Passerini I, Di Iorio V, Della Corte M, Banff S, Surace EM, Menchini U, Auricchio A, Simonelli F, 2012. Correlation between photoreceptor layer integrity and visual function in patients with Stargardt disease: implications for gene therapy. Invest. Ophthalmol. Vis. Sci 53, 4409–4415.
Not in our library10.1167/iovs.11-8201
254.
Testa F, Melillo P, Di Iorio V, Orrico A, Attanasio M, Rossi S, Simonelli F, 2014. Macular function and morphologic features in juvenile stargardt disease: longitudinal study. Ophthalmology 121, 2399–2405.
Not in our library10.1016/j.ophtha.2014.06.032
255.
Teussink MM, Lee MD, Smith RT, van Huet RA, Klaver CC, Klevering BJ, Theelen T, Hoyng CB, 2015. The effect of light deprivation in patients with Stargardt disease. Am. J. Ophthalmol 159, 964–972 e962.
Not in our library10.1016/j.ajo.2015.02.004
256.
Tosha C, Gorin MB, Nusinowitz S, 2010. Test-retest reliability and inter-ocular symmetry of multi-focal electroretinography in Stargardt disease. Curr. Eye Res 35, 63–72.
Not in our library10.3109/02713680903374224
257.
Tracewska AM, Kocyla-Karczmarewicz B, Rafalska A, Murawska J, Jakubaszko-Jablonska J, Rydzanicz M, Stawinski P, Ciara E, Khan MI, Henkes A, Hoischen A, Gilissen C, van de Vorst M, Cremers FPM, Ploski R, Chrzanowska KH, 2019. Genetic spectrum of ABCA4-associated retinal degeneration in Poland. Genes (Basel) 10, E959.
Not in our library10.3390/genes10120959
258.
Trapani I, 2019. Adeno-associated viral vectors as a tool for large gene delivery to the retina. Genes (Basel) 10, E287.
Not in our library10.3390/genes10040287
259.
Effective delivery of large genes to the retina by dual AAV vectors · 2013
No notice
260.
Trapani I, Toriello E, de Simone S, Colella P, Iodice C, Polishchuk EV, Sommella A, Colecchi L, Rossi S, Simonelli F, Giunti M, Bacci ML, Polishchuk RS, Auricchio A, 2015. Improved dual AAV vectors with reduced expression of truncated proteins are safe and effective in the retina of a mouse model of Stargardt disease. Hum. Mol. Genet 24, 6811–6825.
Not in our library10.1093/hmg/ddv386
261.
Tsybovsky Y, Palczewski K, 2014. Expression, purification and structural properties of ABC transporter ABCA4 and its individual domains. Protein Expr. Purif 97, 50–60.
Not in our library10.1016/j.pep.2014.02.010
262.
Tsybovsky Y, Molday RS, Palczewski K, 2010. The ATP-binding cassette transporter ABCA4: structural and functional properties and role in retinal disease. Adv. Exp. Med. Biol 703, 105–125.
Not in our library10.1007/978-1-4419-5635-4_8
263.
Tsybovsky Y, Orban T, Molday RS, Taylor D, Palczewski K, 2013. Molecular organization and ATP-induced conformational changes of ABCA4, the photoreceptor-specific ABC transporter. Structure 21, 854–860.
Not in our library10.1016/j.str.2013.03.001
264.
Turcotte Gauthier MT, 2010. Etude clinique et genetique d’une nouvelle forme d’ataxie spinocerebelleuse pure associee a l’erythrokeratodermie, Faculte de Medecine. Univ. Montreal
Not in our library
265.
Valverde D, Riveiro-Alvarez R, Bernal S, Jaakson K, Baiget M, Navarro R, Ayuso C, 2006. Microarray-based mutation analysis of the ABCA4 gene in Spanish patients with Stargardt disease: evidence of a prevalent mutated allele. Mol. Vis 12, 902–908.
Not in our library
266.
van Driel MA, Maugeri A, Klevering BJ, Hoyng CB, Cremers FP, 1998. ABCR unites what ophthalmologists divide(s). Ophthalmic Genet 19, 117–122.
Not in our library10.1076/opge.19.3.117.2187
267.
van Huet RA, Bax NM, Westeneng-Van Haaften SC, Muhamad M, Zonneveld-Vrieling MN, Hoefsloot LH, Cremers FP, Boon CJ, Klevering BJ, Hoyng CB, 2014. Foveal sparing in Stargardt disease. Invest. Ophthalmol. Vis. Sci 55, 7467–7478.
Not in our library10.1167/iovs.13-13825
268.
Vandenbroucke T, Buyl R, De Zaeytijd J, Bauwens M, Uvijls A, De Baere E, Leroy BP, 2015. Colour vision in stargardt disease. Ophthalmic Res 54, 181–194.
Not in our library10.1159/000438906
269.
Vazquez-Dominguez I, Garanto A, Collin RWJ, 2019. Molecular Therapies for Inherited Retinal Diseases-Current Standing, Opportunities and Challenges. Genes, Basel 10.
Not in our library10.3390/genes10090654
270.
Verbakel SK, van Huet RAC, Boon CJF, den Hollander AI, Collin RWJ, Klaver CCW, Hoyng CB, Roepman R, Klevering BJ, 2018. Non-syndromic retinitis pigmentosa. Prog. Retin. Eye Res 66, 157–186.
Not in our library10.1016/j.preteyeres.2018.03.005
271.
Verdina T, Tsang SH, Greenstein VC, Zernant J, Sodi A, Lima LH, Chang S, Allikmets R, Menchini U, 2012. Functional analysis of retinal flecks in stargardt disease. J. Clin. Exp. Ophthalmol 3.
Not in our library10.4172/2155-9570.1000233
272.
von Ruckmann A, Fitzke FW, Bird AC, 1995. Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br. J. Ophthalmol 79, 407–412.
Not in our library10.1136/bjo.79.5.407
273.
von Ruckmann A, Fitzke FW, Bird AC, 1997. In vivo fundus autofluorescence in macular dystrophies. Arch. Ophthalmol 115, 609–615.
Not in our library10.1001/archopht.1997.01100150611006
274.
Webster AR, Heon E, Lotery AJ, Vandenburgh K, Casavant TL, Oh KT, Beck G, Fishman GA, Lam BL, Levin A, Heckenlively JR, Jacobson SG, Weleber RG, Sheffield VC, Stone EM, 2001. An analysis of allelic variation in the ABCA4 gene. Invest. Ophthalmol. Vis. Sci 42, 1179–1189.
Not in our library
275.
Weng J, Mata NL, Azarian SM, Tzekov RT, Birch DG, Travis GH, 1999. Insights into the function of Rim protein in photoreceptors and etiology of Stargardťs disease from the phenotype in abcr knockout mice. Cell 98, 13–23.
Not in our library10.1016/s0092-8674(00)80602-9
276.
Wolock CJ, Stong N, Ma CJ, Nagasaki T, Lee W, Tsang SH, Kamalakaran S, Goldstein DB, Allikmets R, 2019. A case-control collapsing analysis identifies retinal dystrophy genes associated with ophthalmic disease in patients with no pathogenic ABCA4 variants. Genet. Med 21, 2336–2344.
Not in our library10.1038/s41436-019-0495-0
277.
Wu Y, Fishkin NE, Pande A, Pande J, Sparrow JR, 2009. Novel lipofuscin bisretinoids prominent in human retina and in a model of recessive Stargardt disease. J. Biol. Chem 284, 20155–20166.
Not in our library10.1074/jbc.m109.021345
278.
Yamamoto K, Yoon KD, Ueda K, Hashimoto M, Sparrow JR, 2011. A novel bisretinoid of retina is an adduct on glycerophosphoethanolamine. Invest. Ophthalmol. Vis. Sci 52, 9084–9090.
Not in our library10.1167/iovs.11-8632
279.
Yanik M, Muller B, Song F, Gall J, Wagner F, Wende W, Lorenz B, Stieger K, 2017. In vivo genome editing as a potential treatment strategy for inherited retinal dystrophies. Prog. Retin. Eye Res 56, 1–18.
Not in our library10.1016/j.preteyeres.2016.09.001
280.
Yatsenko AN, Shroyer NF, Lewis RA, Lupski JR, 2001. Late-onset Stargardt disease is associated with missense mutations that map outside known functional regions of ABCR (ABCA4). Hum. Genet 108, 346–355.
Not in our library10.1007/s004390100493
281.
Yatsenko AN, Shroyer NF, Lewis RA, Lupski JR, 2003. An ABCA4 genomic deletion in patients with Stargardt disease. Hum. Mutat 21, 636–644.
Not in our library10.1002/humu.10219
282.
Young RW, 1967. The renewal of photoreceptor cell outer segments. J. Cell Biol 33, 61–72.
Not in our library10.1083/jcb.33.1.61
283.
Young RW, Bok D, 1969. Participation of the retinal pigment epithelium in the rod outer segment renewal process. J. Cell Biol 42, 392–403.
Not in our library10.1083/jcb.42.2.392
284.
Zernant J, Collison FT, Lee W, Fishman GA, Noupuu K, Yuan B, Cai C, Lupski JR, Yannuzzi LA, Tsang SH, Allikmets R, 2014a. Genetic and clinical analysis of ABCA4-associated disease in African American patients. Hum. Mutat 35,1187–1194.
Not in our library10.1002/humu.22626
285.
Zernant J, Xie YA, Ayuso C, Riveiro-Alvarez R, Lopez-Martinez MA, Simonelli F, Testa F, Gorin MB, Strom SP, Bertelsen M, Rosenberg T, Boone PM, Yuan B, Ayyagari R, Nagy PL, Tsang SH, Gouras P, Collison FT, Lupski JR, Fishman GA, Allikmets R, 2014b. Analysis of the ABCA4 genomic locus in Stargardt disease. Hum. Mol. Genet 23, 6797–6806.
Not in our library10.1093/hmg/ddu396
286.
Zernant J, Lee W, Collison FT, Fishman GA, Sergeev YV, Schuerch K, Sparrow JR, Tsang SH, Allikmets R, 2017. Frequent hypomorphic alleles account for a significant fraction of ABCA4 disease and distinguish it from age-related macular degeneration. J. Med. Genet 54, 404–412.
Not in our library10.1136/jmedgenet-2017-104540
287.
Zernant J, Lee W, Nagasaki T, Collison FT, Fishman GA, Bertelsen M, Rosenberg T, Gouras P, Tsang SH, Allikmets R, 2018. Extremely hypomorphic and severe deep intronic variants in the ABCA4 locus result in varying Stargardt disease phenotypes. Cold Spring Harb Mol Case Stud 4.
Not in our library10.1101/mcs.a002733
288.
Zhang Q, Zulfiqar F, Xiao X, Riazuddin SA, Ahmad Z, Caruso R, MacDonald I, Sieving P, Riazuddin S, Hejtmancik JF, 2007. Severe retinitis pigmentosa mapped to 4pl5 and associated with a novel mutation in the PROM1 gene. Hum. Genet 122, 293–299.
Not in our library10.1007/s00439-007-0395-2
289.
Zhang N, Tsybovsky Y, Kolesnikov AV, Rozanowska M, Swider M, Schwartz SB, Stone EM, Palczewska G, Maeda A, Kefalov VJ, Jacobson SG, Cideciyan AV, Palczewski K, 2015. Protein misfolding and the pathogenesis of ABCA4-associated retinal degenerations. Hum. Mol. Genet 24, 3220–3237.
Not in our library10.1093/hmg/ddv073
290.
Zolnikova IV, Strelnikov VV, Skvortsova NA, Tanas AS, Barh D, Rogatina EV, Egorova IV, Levina DV, Demenkova ON, Prikaziuk EG, Ivanova ME, 2017. Stargardt disease-associated mutation spectrum of a Russian Federation cohort. Eur. J. Med. Genet 60, 140–147.
Not in our library10.1016/j.ejmg.2016.12.002

Cited by papers we hold 3

Systemic complement activation levels in Stargardt disease. · 2021
Not checked
A study of elective genome sequencing and pharmacogenetic testing in an unselected population · 2021
Not checked
Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications · 2021
Corrected

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.